Inventor · Cordova, TN, US

Richard E. Lee

20Patents
3h-index
47Co-inventors
59Inventor score

Filing activity: May 17, 2002 → Apr 15, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US6951961B2 Methods of use and compositions for the diagnosis and treatment of infectious disease Chemistry; Metallurgy 8 Expired
US7456222B2 Anti tubercular drug: compositions and methods Emerging Cross-Sectional Technologies 7 Expired
US10266544B2 Aryl substituted aminomethyl spectinomycin analogs as antibacterial agents Human Necessities 4 Active
US7842729B2 Anti tubercular drug: compositions and methods Emerging Cross-Sectional Technologies 2 Expired
US10100090B2 Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase Emerging Cross-Sectional Technologies 2 Active
US8552208B2 Analogs of tetramic acid Chemistry; Metallurgy 2 Active
US9593136B2 Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase Physics 2 Active
US10899734B2 Small molecule modulators of pantothenate kinases Chemistry; Metallurgy 2 Active
US9879050B2 Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase Emerging Cross-Sectional Technologies 2 Active
US8685978B2 Spectinamides as anti-tuberculosis agents Human Necessities 1 Active
US9284325B2 Spectinamides as anti-tuberculosis agents Human Necessities 0 Active
US10570179B2 Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase Human Necessities 0 Active
US11891378B2 Small molecule modulators of pantothenate kinases Human Necessities 0 Active
US10011589B2 Treatments for gastrointestinal conditions Chemistry; Metallurgy 0 Active
US10457707B2 Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase Emerging Cross-Sectional Technologies 0 Active
US10676510B2 Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase Emerging Cross-Sectional Technologies 0 Active
US8268894B2 Compositions and methods for the treatment of infectious diseases Emerging Cross-Sectional Technologies 0 Active
US12115225B2 GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof Chemistry; Metallurgy 0 Active
US11547709B2 Methods of treating disorders associated with castor Human Necessities 0 Active
US10822377B2 Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.